Government Health Care Rationing: Sorry Ladies, No Drugs for You

jenny erikson
Jenny Erikson
Last week we learned that ObamaCare hurts small to medium businesses by offering special waivers to the big boys like McDonald's. What good are rules if they keep changing?

It's (relatively) easy to pass a law requiring all citizens to purchase health insurance. The difficulty lies in actually providing medical attention to everyone who needs it. Here's a secret that Nancy Pelosi forgot to tell you: Health insurance does not equal health care.


Since the government can't force anyone to be a doctor, nurse, or drug-developing scientist, there's a finite number of health care providers. In a free market, people rise up to supply the demands of society. In an ObamaCare world, people don't want to be doctors anymore, because there's just too much hassle and red tape involved with government-run health care.

Now we have fewer doctors and more people wanting cheap (or free!) medical attention. (Sidebar: When are accountants going to be mandated? Because I could sure use one of those to figure out my taxes.) Something has got to give; the question is what?

Apparently the answer is services and drugs specifically for women. Last year, the U.S. Preventative Task Force recommended a reduction in the number of mammograms women receive in their 40s and beyond.

Recently, the FDA has been playing around with rationing the use of Avastin for women with breast cancer. The cutting-edge drug has been proven to extend the lives of women suffering from advanced breast cancer. The drug could still be marketed to treat other cancers such colon and lung cancer. This move suggests that the FDA is keen on rationing women's access to health care.

From Holly Pitt Young:

When the FDA takes something "off label," it is actually rationing treatment. It essentially gives Medicare and most insurance companies permission and justification to deny coverage for the medication.

Government health care at work: Good-bye innovation, hello rationing.


Image via Tech Askew

Read More >